Chair and CEO of $R sells 7,278 shares in insider sale

Roberto E. Sanchez, who holds the positions of Chair and CEO at $R, recently carried out a significant transaction involving the sale of 7,278 shares of the company on July 29, 2025, for an approximate sum of $1,332,383. This move equated to the divestment of around 11.8% of the shares in this particular class of stock, leaving Sanchez with a remaining ownership of 54,364 shares within this category of $R stock.

An analysis of the insider trading activity related to $R reveals a total of 14 trading instances conducted by internal stakeholders over the past half-year period. Among these transactions, none involved purchases, while all 14 were sales. Specifically, Robert E. Sanchez participated in 7 sales, offloading a total of 62,622 shares valued at an estimated $10,890,909. John S. Sensing, functioning as the President of Global SCS & DTS, engaged in 2 sales, selling off 37,463 shares for a total of $5,994,973. Other executives such as John J. Diez, Robert D. Fatovic, Cristina Gallo-Aquino, Luis P. Jr Nieto, and E. Follin Smith also partook in selling shares of $R during this span.

Turning our attention to hedge fund activities surrounding $R, significant movement has been observed with 188 institutional investors opting to augment their holdings of $R stock, juxtaposed against 214 entities that opted to curtail their positions during the most recent quarter. Notable actions include Valeo Financial Advisors, LLC adding a substantial 2,862,970 shares to their portfolio in Q2 2025, a remarkable increase of 51455.2%, and Wealthfront Advisers LLC decreasing their holdings by 100.0%. Information on the stock portfolios of various hedge funds is visible through Quiver Quantitative’s institutional holdings dashboard.

Furthermore, Wall Street analysts have provided detailed reports on $R, with a consensus of 5 firms issuing buy ratings, while none have issued sell ratings during recent months. Notable ratings have been issued by prominent firms such as Morgan Stanley, Baird, Susquehanna, Wolfe Research, and Barclays, each emphasizing positive outlooks on the stock. Median price targets for $R have been elucidated by multiple analysts, with 7 analysts setting a median target of $190.0. Such specific evaluations are crucial for investors seeking to make informed decisions regarding their investments. It is important to note that the content of this article should not be misconstrued as financial advice, and readers are encouraged to review Quiver Quantitative’s disclaimers for further information.